Eyes On FTC After Canada's Drug Sampling Probe Flops
The U.S. Federal Trade Commission has been actively searching for a case to bring against branded drugmakers the agency suspects of trying to prevent generics companies from developing cheaper rivals to...To view the full article, register now.
Already a subscriber? Click here to view full article